Undergoing hormone therapy may be effective in reducing age-related curvature of the spine in post-menopausal women, finds a study.
Hyperkyphosis, sometimes called dowager's hump, is an exaggerated curvature of the spine that creates a forward stooped posture.
Beyond its adverse aesthetic effects, hyperkyphosis is associated with poor physical function, an increased risk of falls and fractures, and earlier mortality.
Women who reported continuous or remote past hormone therapy use had less pronounced kyphosis by the time they were in their mid-80s than never-users.
The results support the argument for hormone therapy as a possible early post-menopause treatment for women concerned about their posture and fracture risk, the researchers said.
"Women who reported early use of hormone therapy were less likely to develop age-related kyphosis, and the protective benefits continued even after stopping the therapy," said JoAnn Pinkerton, Executive Director at the North American Menopause Society (NAMS) -- a US-based non-profit organisation.
"This supports a benefit of prescribing hormone therapy close to menopause," Pinkerton added in a paper published in the journal Menopause.
It is well known that the significant declines in estrogen experienced during the menopause transition contribute to accelerated bone loss. Hormone therapy has been known to help reverse bone loss and prevent fractures.
Given that hyperkyphosis is also associated with bone loss and vertebral fractures, the researchers hypothesised that hormone therapy may also be effective in helping prevent exaggerated spine curvature.
The team involved more than 9,700 women aged 65 years and older who were evaluated over a 15-year period.
During the first three years of hormone therapy use, bone density has been shown to increase steadily and then is maintained during continued use.
--IANS
rt/nks/sac
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
